Order Article Reprints

Cybula M, Wang L, Wang L, Drumond-Bock AL, Moxley KM, Benbrook DM, Gunderson-Jackson C, Ruiz-Echevarria MJ, Bhattacharya R, Mukherjee P, et al. Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research. Cancers. 2021; 13(24):6288. https://doi.org/10.3390/cancers13246288

Cybula, Magdalena, Lin Wang, Luyao Wang, Ana Luiza Drumond-Bock, Katherine M. Moxley, Doris M. Benbrook, Camille Gunderson-Jackson, Maria J. Ruiz-Echevarria, Resham Bhattacharya, Priyabrata Mukherjee, and et al. 2021. "Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research" Cancers 13, no. 24: 6288. https://doi.org/10.3390/cancers13246288

Cybula, M., Wang, L., Wang, L., Drumond-Bock, A. L., Moxley, K. M., Benbrook, D. M., Gunderson-Jackson, C., Ruiz-Echevarria, M. J., Bhattacharya, R., Mukherjee, P., & Bieniasz, M. (2021). Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research. Cancers, 13(24), 6288. https://doi.org/10.3390/cancers13246288